LeMaitre Vascular (LMAT)
(Delayed Data from NSDQ)
$89.04 USD
-0.82 (-0.91%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $89.05 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$89.04 USD
-0.82 (-0.91%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $89.05 +0.01 (0.01%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum D VGM
Zacks News
Zacks.com highlights: Stamps.com, ICU Medical, LeMaitre Vascular, United States Cellular and Everest Re Group
by Zacks Equity Research
Zacks.com highlights: Stamps.com, ICU Medical, LeMaitre Vascular, United States Cellular and Everest Re Group
Boost Immunity to Market Volatility With 5 Low-Beta Stocks
by Zacks Equity Research
We have developed a strategy which clearly shows that stocks with low risk could also reward investors with handsome returns.
Stryker (SYK) to Gain From Solid Portfolio and Acquisitions
by Zacks Equity Research
Stryker's (SYK) diverse portfolio and accretive acquisitions is instrumental in aiding the company's top-line growth.
Stryker (SYK) to Gain From Solid Portfolio and Acquisitions
by Zacks Equity Research
Stryker Corporation (SYK) has successfully expanded its product portfolio over time, which aids the company to cater to evolving demands of customers.
Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength
by Zacks Equity Research
Luminex Corp (LMNX) is focusing on augmenting its portfolio strength through new FDA approvals.
5 MedTech Stocks to Pick for Stellar Returns
by Zacks Equity Research
While the MedTech industry has been grappling with multiple issues, these stocks with high growth potential can be great bets.
5 Top-Ranked MedTech Growth Stocks for Solid Returns
by Zacks Equity Research
Despite the ongoing turmoil in the MedTech industry, these stocks with high growth potential can be great bets for investors.
Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead
by Zacks Equity Research
The share price performance of Abbott Laboratories (ABT) has been disappointing over the last three years. Of the prime issues plaguing Abbott, foreign exchange is a major one.
Why LeMaitre Vascular (LMAT) Could Be Positioned for a Surge
by Zacks Equity Research
LeMaitre Vascular (LMAT) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.
Top Ranked Momentum Stocks to Buy for August 8th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 8th:
LeMaitre Vascular (LMAT) Worth a Look: Stock Jumps 19.5%
by Zacks Equity Research
LeMaitre Vascular, Inc. (LMAT) shares jumped above 19% in the last trading session.
Top Ranked Momentum Stocks to Buy for July 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 31st:
Time to Focus on LeMaitre Vascular (LMAT) for Strong Earnings Growth Potential
by Zacks Equity Research
LeMaitre Vascular (LMAT) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.
7 Stocks to Buy with Impressive Interest Coverage Ratio
by Zacks Equity Research
A company's fundamentals should be sound enough to meet its financial obligations. This can be judged through coverage ratios.
Can The Uptrend Continue for LeMaitre Vascular (LMAT)?
by Zacks Equity Research
Investors certainly have to be happy with LeMaitre Vascular Inc (LMAT) and its short term performance
Top Ranked Momentum Stocks to Buy for April 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 28th:
Medical Device Stocks to Beat Estimates this Earnings Season
by Zacks Equity Research
Most of the MedTech majors will be releasing earnings later this month.
Get Ready To Be Surprised This Earnings Season
by Kevin Matras
Kevin Matras details a good screen to use before and after a company reports this earnings season. Highlighted stocks include COR, LMAT, TSO, ATVI and TECD.